Oncobiologics, Inc. - 54 Year Dividend History | OTLK
Historical dividend payout and yield for Oncobiologics, Inc. (OTLK) since 1971. The current TTM dividend payout for Oncobiologics, Inc. (OTLK) as of February 21, 2025 is $0.00. The current dividend yield for Oncobiologics, Inc. as of February 21, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.050B |
$0.000B |
|
Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
